These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38814539)

  • 1. Repeated Exposure of Vancomycin to Vancomycin-Susceptible Staphylococcus aureus (VSSA) Parent Emerged VISA and VRSA Strains with Enhanced Virulence Potentials.
    Nguyen A; Roy JJS; Kim JH; Yun KH; Lee W; Kim KK; Kim T; Chaurasia AK
    J Microbiol; 2024 May; ():. PubMed ID: 38814539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive
    Jin Y; Yu X; Zhang S; Kong X; Chen W; Luo Q; Zheng B; Xiao Y
    Front Microbiol; 2020; 11():596942. PubMed ID: 33193280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
    Tiwari HK; Sen MR
    BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Susceptibility and Resistance to Vancomycin of Staphylococcus aureus: A Review of Global Incidence Patterns and Related Genetic Mechanisms.
    Unni S; Siddiqui TJ; Bidaisee S
    Cureus; 2021 Oct; 13(10):e18925. PubMed ID: 34812309
    [No Abstract]   [Full Text] [Related]  

  • 5. Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitors.
    Cameron DR; Lin YH; Trouillet-Assant S; Tafani V; Kostoulias X; Mouhtouris E; Skinner N; Visvanathan K; Baines SL; Howden B; Monk IR; Laurent F; Stinear TP; Howden BP; Peleg AY
    Clin Microbiol Infect; 2017 Oct; 23(10):767-773. PubMed ID: 28396035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin Resistance in
    McGuinness WA; Malachowa N; DeLeo FR
    Yale J Biol Med; 2017 Jun; 90(2):269-281. PubMed ID: 28656013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug and vancomycin resistance among clinical isolates of
    Olufunmiso O; Tolulope I; Roger C
    Afr Health Sci; 2017 Sep; 17(3):797-807. PubMed ID: 29085408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus.
    Yoo JI; Kim JW; Kang GS; Kim HS; Yoo JS; Lee YS
    J Microbiol; 2013 Apr; 51(2):160-5. PubMed ID: 23625215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.
    Gardete S; Kim C; Hartmann BM; Mwangi M; Roux CM; Dunman PM; Chambers HF; Tomasz A
    PLoS Pathog; 2012 Feb; 8(2):e1002505. PubMed ID: 22319446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
    Tran N; Rybak MJ
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of extracellular polysaccharide and biofilm under different oxygen conditions by clinical isolates of Staphylococcus aureus non-susceptible to glycopeptides.
    Szymanek-Majchrzak K; Wodzyńska S; Młynarczyk A; Młynarczyk G
    Przegl Epidemiol; 2018; 72(4):487-498. PubMed ID: 30810004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.
    Passalacqua KD; Satola SW; Crispell EK; Read TD
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5212-23. PubMed ID: 22850507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A vancomycin resistance-associated WalK(S221P) mutation attenuates the virulence of vancomycin-intermediate Staphylococcus aureus.
    Rao Y; Peng H; Shang W; Hu Z; Yang Y; Tan L; Li M; Zhou R; Rao X
    J Adv Res; 2022 Sep; 40():167-178. PubMed ID: 36100324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.
    Howden BP; Smith DJ; Mansell A; Johnson PD; Ward PB; Stinear TP; Davies JK
    BMC Microbiol; 2008 Feb; 8():39. PubMed ID: 18304359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of vancomycin resistant
    Hasan R; Acharjee M; Noor R
    Ci Ji Yi Xue Za Zhi; 2016; 28(2):49-53. PubMed ID: 28757721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of vancomycin resistance in Staphylococcus aureus.
    Gardete S; Tomasz A
    J Clin Invest; 2014 Jul; 124(7):2836-40. PubMed ID: 24983424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate
    Hu Q; Peng H; Rao X
    Front Microbiol; 2016; 7():1601. PubMed ID: 27790199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.
    Howden BP; Peleg AY; Stinear TP
    Infect Genet Evol; 2014 Jan; 21():575-82. PubMed ID: 23567819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.